ASENSUS SURGICAL, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Loss (gain) from sale of assets, net
AutoLap
SurgiBot System
Gain (loss) from sale of assets, net
Auto Lap
SurgiBot System
Goodwill and intangible assets impairment
Depreciation
Amortization of intangible assets
Amortization of debt discount and debt issuance costs
Amortization of discounts and premiums on investments, net
Stock-based compensation
Interest expense on deferred consideration - MST acquisition
Gain on extinguishment of debt
Deferred tax expense
Change in inventory reserves
Bad debt expense
Deferred tax benefit
Write down of inventory
SurgiBot System
Total write down of inventory
Impairment of property and equipment
Loss on disposal of property and equipment
Change in fair value of warrant liabilities
Reversal of transfer fee accrual
Change in fair value of contingent consideration

Changes in operating assets and liabilities:
Accounts receivable
Interest receivable
Inventories
Operating lease right-of-use assets
Prepaid expenses
Employee retention tax credit receivable
Other current and long-term assets
Accounts payable
Accrued employee compensation and benefits
Accrued expenses
Deferred revenue
Operating lease liabilities
Other long-term liabilities
Net cash and cash equivalents used in operating activities

Investing Activities:
Proceeds related to sale of assets, net
AutoLap
SurgiBot System
Proceeds from sale of AutoLap assets
Purchase of available-for-sale investments
Payment for acquisition of a business
Proceeds from maturities of available-for-sale investments
Purchase of property and equipment
Proceeds from sale of property and equipment
Net cash and cash equivalents provided by (used in) investing activities

Financing Activities:
Proceeds from issuance of common stock, preferred stock and warrants under 2020 financing, net of issuance costs
Proceeds from issuance of common stock, net of issuance costs
Proceeds from notes payable, net of issuance costs
Payment of note payable
Proceeds from issuance of debt and warrants, net of issuance costs
Taxes paid related to net share settlement of vesting of restricted stock units
Proceeds from issuance of common stock related to sale of SurgiBot assets
Payment of contingent consideration
Proceeds from issuance of common stock and warrants, net of issuance costs
Proceeds from exercise of stock options and warrants
Net cash and cash equivalents (used in) provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period

Supplemental Disclosure for Cash Flow Information
Interest paid
Cash paid for leases
Cash paid for taxes
Supplemental Schedule of Non-cash Investing and Financing Activities:
Reclass of warrant liability to common stock and additional paid-in capital
Cashless exercise of warrants
Transfer of inventories to property and equipment
Reclass of warrant liability to common stock and additional paid-in-capital
Exchange of common stock for Series B Warrants
Deferred consideration - MST acquisition
Transfer of in-process research and development to intellectual property
Deemed dividend related to beneficial conversion feature of preferred stock
Deemed dividend related to conversion of preferred stock into common stock
Issuance of common stock - MST acquisition
Proceeds from sale of AutoLap assets exchanged for settlement of Company obligations
Transfer of property and equipment to inventories
Conversion of preferred stock to common stock
Lease liabilities arising from obtaining right-of-use assets

Comments